Skip to main content

Table 2 Basic information of participants in the second batch verification queue

From: Deciphering the omicron variant: integrated omics analysis reveals critical biomarkers and pathophysiological pathways

 

Healthy controls

Omicron

P

N

20

20

 

Age

54.00 (36.75–58.75)

53.00 (46.00–62.00)

0.580

WBC, 109/L

6.64 (5.35–9.27)

5.80 (4.62–7.85)

0.229

NEU %

53.88 (44.30–61.44)

92.66 (73.34–105.28)

 < 0.001

LYM %

29.37 (26.30–34.81)

16.71 (13.34–28.89)

 < 0.001

MONO %

6.98 (5.34–8.29)

12.33 (10.61–14.60)

 < 0.001

EOS %

1.45 (0.88–3.38)

1.65 (0.93–2.10)

0.839

BASO %

0.86 (0.38–1.13)

0.17 (0.10–0.22)

 < 0.001

NEU, 109/L

5.00 (3.67–6.05)

5.28 (2.65–5.53)

0.655

LYM, 109/L

2.40 (1.80–3.15)

1.50 (0.80–2.30)

0.004

MONO, 109/L

0.44 (0.26–0.65)

0.42 (0.37–0.66)

0.960

EOS, 109/L

0.22 (0.16–0.37)

0.15 (0.08–0.21)

0.004

BASO, 109/L

0.02 (0.01–0.03)

0.03 (0.02–0.03)

0.194

PT, S

12.45 (11.73–13.40)

14.00 (12.85–14.58)

0.003

INR

0.75 (0.60–0.90)

0.90 (0.80–1.18)

0.060

PTTA, %

97.00 (92.43–109.00)

83.20 (76.25–94.10)

 < 0.001

FIB, g/L

2.90 (2.53–3.45)

4.74 (3.53–5.52)

 < 0.001

APTT, S

35.70 (31.50–40.15)

41.40 (31.85–47.18)

0.048

TT, S

16.15 (15.23–18.78)

16.55 (15.20–18.33)

0.745

D-Dimer, μg/L

297.00 (211.00–364.75)

510.00 (439.50–603.50)

 < 0.001

CRP, mg/dL

2.75 (1.65–4.13)

8.50 (5.80–10.40)

 < 0.001

SAA, mg/L

5.50 (3.10–8.38)

35.75 (30.48–44.88)

 < 0.001

PCT, ng/mL

0.02 (0.01–0.05)

0.09 (0.06–0.15)

 < 0.001

  1. WBC White blood cell, NEU Neutrophil, LYM Lymphocyte, MONO Monocyte, EOS Eosinophils, BASO Basophil, PT Prothrombin time, INR International normalized ratio, PTTA Prothrombin activity, FIB Fibrinogen, APTT Activated partial thromboplastin time, TT Thrombin, DD D-Dimer, CRP C-reactive protein, SAA Serumamyloid A, PCT Procalcitonin